[go: up one dir, main page]

NO20033722L - Aktuatorer for trykksatte inhalatorer for tilmålt dose og produkter for medisinsk aerosollösningsformulering omfattende disse aktuatorer - Google Patents

Aktuatorer for trykksatte inhalatorer for tilmålt dose og produkter for medisinsk aerosollösningsformulering omfattende disse aktuatorer

Info

Publication number
NO20033722L
NO20033722L NO20033722A NO20033722A NO20033722L NO 20033722 L NO20033722 L NO 20033722L NO 20033722 A NO20033722 A NO 20033722A NO 20033722 A NO20033722 A NO 20033722A NO 20033722 L NO20033722 L NO 20033722L
Authority
NO
Norway
Prior art keywords
actuators
metered dose
solution formulation
dose inhalers
pressurized metered
Prior art date
Application number
NO20033722A
Other languages
English (en)
Norwegian (no)
Other versions
NO20033722D0 (no
Inventor
Rebecca Jayne Davies
David Ganderton
David Andrew Lewis
Brian John Meakin
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of NO20033722D0 publication Critical patent/NO20033722D0/no
Publication of NO20033722L publication Critical patent/NO20033722L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20033722A 2001-12-21 2003-08-21 Aktuatorer for trykksatte inhalatorer for tilmålt dose og produkter for medisinsk aerosollösningsformulering omfattende disse aktuatorer NO20033722L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01130521A EP1321159A1 (fr) 2001-12-21 2001-12-21 Dispositif d'actionnement pour inhalateur doseur pressurisé avec orifices percés par laser
PCT/EP2002/014588 WO2003053501A1 (fr) 2001-12-21 2002-12-19 Aerosol-doseur

Publications (2)

Publication Number Publication Date
NO20033722D0 NO20033722D0 (no) 2003-08-21
NO20033722L true NO20033722L (no) 2003-10-20

Family

ID=8179630

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033722A NO20033722L (no) 2001-12-21 2003-08-21 Aktuatorer for trykksatte inhalatorer for tilmålt dose og produkter for medisinsk aerosollösningsformulering omfattende disse aktuatorer

Country Status (16)

Country Link
US (2) US20050061314A1 (fr)
EP (3) EP1321159A1 (fr)
JP (2) JP2005512691A (fr)
AU (2) AU2002361179B2 (fr)
BR (1) BR0207631A (fr)
CA (1) CA2470857A1 (fr)
EA (1) EA006754B1 (fr)
GE (1) GEP20064002B (fr)
HR (1) HRP20040559A2 (fr)
HU (1) HUP0402487A2 (fr)
NO (1) NO20033722L (fr)
NZ (1) NZ534040A (fr)
PL (1) PL369072A1 (fr)
UA (1) UA75770C2 (fr)
WO (2) WO2003053501A1 (fr)
YU (1) YU64804A (fr)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US8409846B2 (en) 1997-09-23 2013-04-02 The United States Of America As Represented By The Department Of Veteran Affairs Compositions, methods and devices for maintaining an organ
ES2377819T3 (es) * 2002-08-14 2012-04-02 Gw Pharma Limited Formulaciones líquidas cannabinoides para administración mucosal
SG146648A1 (en) * 2003-09-15 2008-10-30 Vectura Ltd Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
US8304181B2 (en) 2004-10-07 2012-11-06 Transmedics, Inc. Method for ex-vivo organ care and for using lactate as an indication of donor organ status
US12010987B2 (en) 2004-10-07 2024-06-18 Transmedics, Inc. Systems and methods for ex-vivo organ care and for using lactate as an indication of donor organ status
US7651835B2 (en) 2004-10-07 2010-01-26 Transmedics, Inc. Method of timing pulsatile flow of normothermic perfusate to the heart
US8028697B2 (en) * 2005-04-28 2011-10-04 Trudell Medical International Ventilator circuit and method for the use thereof
AU2006262195A1 (en) * 2005-06-20 2007-01-04 Unimed Pharmaceuticals, Inc. Dronabinol treatment for migraines
US9078428B2 (en) 2005-06-28 2015-07-14 Transmedics, Inc. Systems, methods, compositions and solutions for perfusing an organ
CA2633353A1 (fr) * 2005-12-21 2007-07-05 Nitrox, Llc Formulations stables de s-nitrosothiol
DE102006014433A1 (de) * 2006-03-27 2007-10-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Dosieraerosole für die Verabreichung von pharmazeutischen Zubereitungen
DE102006022002A1 (de) * 2006-05-10 2007-11-15 Boehringer Ingelheim International Gmbh Zerstäuber und Verfahren zur Zerstäubung von Fluid
US9457179B2 (en) 2007-03-20 2016-10-04 Transmedics, Inc. Systems for monitoring and applying electrical currents in an organ perfusion system
US8062685B2 (en) * 2007-04-03 2011-11-22 Frito-Lay North America, Inc. Direct expanded snack made with peanut flour and method for making
WO2008140869A1 (fr) * 2007-05-10 2008-11-20 3M Innovative Properties Company Fabrication de composants de valve doseuse
EP2011534A1 (fr) * 2007-07-03 2009-01-07 CHIESI FARMACEUTICI S.p.A. Actionneur d'inhalateur à dosage mesuré
US20090151722A1 (en) * 2007-07-06 2009-06-18 Vectura Delivery Devices Limited Inhaler
EP2011537A1 (fr) * 2007-07-06 2009-01-07 Vectura Delivery Devices Limited Inhalateur
EP2077132A1 (fr) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispositif distributeur, dispositif de stockage et procédé pour la distribution d'une formulation
EP2080507A1 (fr) 2008-01-15 2009-07-22 CHIESI FARMACEUTICI S.p.A. Formulations pharmaceutiques comprenant un médicament anticholinérgique
US9814230B2 (en) 2008-01-31 2017-11-14 Transmedics, Inc. Systems and methods for ex vivo lung care
EP2626098B1 (fr) 2008-10-22 2020-08-19 Trudell Medical International Système modulaire d'administration d'un aérosol
WO2010112358A2 (fr) 2009-03-31 2010-10-07 Boehringer Ingelheim International Gmbh Procédé de revêtement d'une surface d'un composant
EP3508239B1 (fr) 2009-05-18 2020-12-23 Boehringer Ingelheim International GmbH Adaptateur, dispositif d'inhalation et pulvérisateur
AU2010323220B2 (en) 2009-11-25 2015-04-23 Boehringer Ingelheim International Gmbh Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011064163A1 (fr) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nébuliseur
PH12012501066A1 (en) 2009-12-23 2016-03-02 Chiesi Farm Spa Combination therapy for copd
WO2011076840A2 (fr) 2009-12-23 2011-06-30 Chiesi Farmaceutici S.P.A. Préparation aérosol pour bronchopneumopathie chronique obstructive
KR101738712B1 (ko) 2009-12-23 2017-05-22 키에시 파르마슈티시 엣스. 피. 에이. Ｃｏｐｄ용 조합요법
EP2515854B1 (fr) 2009-12-23 2014-03-19 Chiesi Farmaceutici S.p.A. Formule d'aérosol pour COPD
US9943654B2 (en) 2010-06-24 2018-04-17 Boehringer Ingelheim International Gmbh Nebulizer
JP6000946B2 (ja) * 2010-07-12 2016-10-05 クセリア ファーマシューティカルズ エーピーエスＸｅｌｌｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ ＡｐＳ 肺感染症の治療のための組成物
EP2694220B1 (fr) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Appareil médical pourvu d'un récipient
WO2012142487A1 (fr) 2011-04-14 2012-10-18 Transmedics, Inc. Solution ocs pour perfusion ex vivo de greffons pulmonaires
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
US20150010527A1 (en) 2012-02-01 2015-01-08 Protalix Ltd. Dnase i polypeptides, polynucleotides encoding same, methods of producing dnase i and uses thereof in therapy
US20150174158A1 (en) 2012-03-07 2015-06-25 Advanced Inhalation Therapies (Ait) Ltd. Inhalation of nitric oxide for treating respiratory diseases
WO2013152894A1 (fr) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Pulvérisateur comprenant des moyens de détrompage
WO2014033057A1 (fr) 2012-08-29 2014-03-06 Chiesi Farmaceutici S.P.A. Dispositif d'inhalation d'aérosol
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
USD772395S1 (en) * 2013-11-29 2016-11-22 Norton (Waterford) Limited Respiratory apparatus
JP6563950B2 (ja) 2013-12-30 2019-08-21 シエシー ファルマセウティチィ ソシエタ ペル アチオニ グリコピロニウム臭化物およびホルモテロールの組合せの安定な加圧エアゾール溶液組成物
GB2524469A (en) 2014-02-14 2015-09-30 Kind Consumer Ltd A cannabinoid inhaler and composition therefor
US9918961B2 (en) 2014-02-19 2018-03-20 Kind Consumer Limited Cannabinoid inhaler and composition therefor
US10722666B2 (en) 2014-05-07 2020-07-28 Boehringer Ingelheim International Gmbh Nebulizer with axially movable and lockable container and indicator
EP3139979B1 (fr) 2014-05-07 2023-07-05 Boehringer Ingelheim International GmbH Unité, nébuliseur et procédé
SG11201608891RA (en) 2014-05-07 2016-11-29 Boehringer Ingelheim Int Nebulizer, indicator device and container
ES2839202T3 (es) 2014-06-02 2021-07-05 Transmedics Inc Sistema de cuidado de órganos ex vivo
WO2015195711A2 (fr) * 2014-06-16 2015-12-23 Shurtleff, James, Kevin Méthode et dispositifs de fabrication et distribution de formulations en aérosol
EP3160445B1 (fr) * 2014-06-26 2021-10-20 Island Breeze Systems Ca, LLC Produits associés à un aérosol doseur, et procédés d'utilisation
WO2016057693A1 (fr) 2014-10-10 2016-04-14 Alnylam Pharmaceuticals, Inc. Procédés et compositions pour administration par inhalation d'oligonucléotide conjugué
ES3030496T3 (en) 2014-12-12 2025-06-30 Transmedics Inc Apparatus and method for organ perfusion
US20180140787A1 (en) * 2015-05-21 2018-05-24 Island Breeze Systems Ca, Llc Propellant based metered dose inhaler and food applicators and applicators
DK3824731T3 (da) 2015-09-09 2025-05-26 Transmedics Inc Aortakanyle til ex vivo-organplejesystem
GB2544477A (en) * 2015-11-16 2017-05-24 3M Innovative Properties Co Improvements in or relating to medical actuators
WO2017167737A1 (fr) 2016-03-31 2017-10-05 Chiesi Farmaceutici S.P.A. Dispositif d'inhalation d'aérosol
CN109310077B (zh) 2016-05-30 2022-06-07 体沃索股份有限公司 利用变化的外部压力用于离体肺通气的装置和方法
US9717683B1 (en) 2016-06-29 2017-08-01 Ep Pharma, Llc Low-temperature inhalation administration of cannabinoid entities
US10098837B2 (en) 2016-07-28 2018-10-16 Chiesi Farmaceutici S.P.A. Combination therapy for COPD
US10231948B2 (en) 2017-02-27 2019-03-19 Jason Ty Nguyen Metered dose inhaler compositions, systems, and methods
US10906728B2 (en) * 2017-06-20 2021-02-02 Aptar France Sas Device for dispensing a fluid product
GB2567240B (en) 2017-10-09 2022-04-06 Senzer Ltd An inhaler particularly a cannabinoid inhaler and a method of assembling such an inhaler
GB201912686D0 (en) * 2019-09-04 2019-10-16 Reown Pharma Inc Pharmaceutical composition
EP3797964B1 (fr) 2019-09-26 2023-06-07 Presspart Manufacturing S.A. Outil de moulage par injection pour inhalateur de dose mesurée
GB2595692B (en) 2020-06-03 2024-10-23 Senzer Ltd A refill for an inhaler particularly a cannabinoid inhaler
WO2021247283A1 (fr) * 2020-06-04 2021-12-09 Amcyte Pharma, Inc. Administration de concentrations micromolaires de composition en aérosol
BR112023019156A2 (pt) 2021-03-23 2023-10-17 1232176 B C Ltd Inalador pressurizado dosimetrado e formulação para uso em um método para tratar uma reação alérgica aguda
WO2025072756A1 (fr) * 2023-09-28 2025-04-03 Kokua Pharma Inc. Dispositif, méthodes et utilisations pour le traitement de réactions allergiques aiguës

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4279824A (en) * 1979-11-01 1981-07-21 Mckinney Laurence O Method and apparatus for processing herbaceous plant materials including the plant cannabis
DE3305755A1 (de) 1983-02-19 1984-08-23 Gödecke AG, 1000 Berlin N-phenyl-benzamid-derivate, verfahren zu deren herstellung und deren verwendung bei der bekaempfung von erkranungen des immunsystems
US5290539A (en) 1990-12-21 1994-03-01 Minnesota Mining And Manufacturing Company Device for delivering an aerosol
GB2276101A (en) 1993-03-19 1994-09-21 Csb Moulds Ltd Spray nozzles for pharmaceutical inhalers
US5389375A (en) * 1993-05-21 1995-02-14 University Of Mississippi Stable suppository formulations effecting bioavailability of Δ9 -thc
US5464154A (en) * 1993-09-29 1995-11-07 Union Carbide Chemicals & Plastics Technology Corporation Methods for spraying polymeric compositions with compressed fluids and enhanced atomization
KR20000069275A (ko) * 1996-12-04 2000-11-25 새들러 테리 아이언 약학 조성물과 그 투여를 위한 장치
BR7702049U (pt) 1997-09-05 1999-09-14 Chiesi Farma Spa Bico pulverizador para utilização em inalador oral para medicamentos aerossóis
GB9726916D0 (en) * 1997-12-19 1998-02-18 Danbiosyst Uk Nasal formulation
DE69909771T2 (de) 1998-04-30 2004-04-15 3M Innovative Properties Co., Saint Paul Dosierventil für pharmazeutisches aerosol
US6008383A (en) 1998-10-26 1999-12-28 University Of Mississippi Method of preparing delta-9-tetrahydrocannabinol esters
US6509005B1 (en) 1998-10-27 2003-01-21 Virginia Commonwealth University Δ9 Tetrahydrocannabinol (Δ9 THC) solution metered dose inhaler
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6209286B1 (en) * 1999-03-09 2001-04-03 Novus Packaging Corporation Machine and method for manufacturing a continuous production of pneumatically filled inflatable packaging pillows
WO2001019342A2 (fr) * 1999-09-11 2001-03-22 Glaxo Group Limited Preparation pharmaceutique renfermant du propionate de fluticasone
GB0002798D0 (en) * 2000-02-09 2000-03-29 Glaxo Group Ltd Actuator nozzle for metered dose inhaler
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.

Also Published As

Publication number Publication date
HUP0402487A2 (hu) 2005-06-28
AU2002361453A1 (en) 2003-07-15
NZ534040A (en) 2006-03-31
JP2005512740A (ja) 2005-05-12
US20050061314A1 (en) 2005-03-24
EA200400730A1 (ru) 2005-02-24
GEP20064002B (en) 2006-12-25
EA006754B1 (ru) 2006-04-28
UA75770C2 (en) 2006-05-15
AU2002361179B2 (en) 2007-10-25
WO2003055549A1 (fr) 2003-07-10
WO2003053501A1 (fr) 2003-07-03
EP1455873A1 (fr) 2004-09-15
AU2002361179A1 (en) 2003-07-09
BR0207631A (pt) 2004-06-01
US20080017191A1 (en) 2008-01-24
HRP20040559A2 (en) 2004-10-31
CA2470857A1 (fr) 2003-07-03
NO20033722D0 (no) 2003-08-21
EP1321159A1 (fr) 2003-06-25
PL369072A1 (en) 2005-04-18
JP2005512691A (ja) 2005-05-12
EP1455874A1 (fr) 2004-09-15
YU64804A (sh) 2006-05-25

Similar Documents

Publication Publication Date Title
NO20033722L (no) Aktuatorer for trykksatte inhalatorer for tilmålt dose og produkter for medisinsk aerosollösningsformulering omfattende disse aktuatorer
DK1306082T3 (da) Afmålte dosisinhalatorer under tryk og farmaceutiske aerosolformuleringer
DK1157689T3 (da) Stabile farmaceutiske oplösningsformuleringer til tryksatte dosis-inhalatorer
DK1397174T3 (da) Pulverformulerings-desintegrationssystem og tørpulverinhalatorer
AU1132102A (en) Coated medical devices and sterilization thereof
DE69942896D1 (de) Druckdosierinhalatoren
ITMI20000300A0 (it) Nebulizzatore medico per liquido da utilizzare nella terapia respiratoria e altre applicazioni
ITMI20000010A0 (it) Dispositivo per la somministrazione di aerosol dosati pressurizzati in propellenti idrofluoroalcani
ATE383868T1 (de) Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka
AU2003243439A8 (en) Medical device for intra-lumenal delivery of pharmaceutical agents
NO20026055D0 (no) Farmasöytisk komponent omfattende human paratyroidhormon og farmasöytisk komponent for nasal administrering inneholdende komponentene
EP1449644A4 (fr) Produit stratifie et fourniture medicale comprenant ce produit stratifie
NO20013141D0 (no) Arylalkanoylderivater, fremgangsmåte for fremstilling derav, deres anvendelse og farmasöytiske produkter inneholdende disse
IL152751A0 (en) Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them
GB0106018D0 (en) Pharmaceutical aerosol formulation
GB0128335D0 (en) Pharmaceutical aerosol formulation
PT1181197E (pt) Embalagem para um produto farmaceutico e metodo para esterilizar a embalagem
SI1448181T1 (sl) Farmacevtski sestavek, ki obsega kombinacijo metformina in 4-oksobutanojske kisline, ter njegova uporaba za zdravljenje diabetesa

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application